gsk-2025-jpm-conf-presentation-14-january-2025.pdf

1、14 January 202514 January 2025Delivering strong and sustained momentumDelivering strong and sustained momentumEmma Walmsley,Chief Executive OfficerJ.P.Morgan Healthcare Conference,San Francisco2This presentation may contain forward-looking statements.Forward-looking statements give the Groups curren

2、t expectations or forecasts of future events.An investor can identify these statements by the fact that they do not relate strictly to historical or current facts.They use words such as anticipate,estimate,expect,intend,will,project,plan,believe,target and other words and terms of similar meaning in

3、 connection with any discussion of future operating or financial performance.In particular,these include statements relating to future actions,prospective products or product approvals,future performance or results of current and anticipated products,sales efforts,expenses,the outcome of contingenci

4、es such as legal proceedings,dividend payments and financial results.Other than in accordance with its legal or regulatory obligations(including under the Market Abuse Regulations,UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority),the Group undert

5、akes no obligation to update any forward-looking statements,whether as a result of new information,future events or otherwise.Investors should,however,consult any additional disclosures that the Group may make in any documents which it publishes and/or files with the US Securities and Exchange Commi

6、ssion(SEC).All investors,wherever located,should take note of these disclosures.Accordingly,no assurance can be given that any particular expectation will be met and investors are cautioned not to place undue reliance on the forward-looking statements.Forward-looking statements are subject to assump